APS Logo

Biomarkers of Myotonic Dystrophy Type I (DM1) with rsfMRI and neuropsychological assessment.

ORAL

Abstract

Myotonic Dystrophy Type I (DM1) is a neurodegenerative and hereditary disorder; its more typical symptoms are muscle weakness and hypotonia, which may lead to several complications like respiratory failure and cardiac arrest. The aim of this study is to find biomarkers that help us to characterize the evolution of this disorder related neuropsychological process and the Blood Oxygen Level Dependent (BOLD) functional connectivity in the brain. In the present work 44 volunteer participants (22 classic DM1 patients, and 22 healthy control subjects) were matched by age, gender and level education, then underwent an MRI session in a 3T Philips Ingenia scanner with a 32 channel head sense coil. The parameters for the resting state fMRI data are sequence FE-EPI, TR=2000ms, TE=30 ms and 3mm3 spatial resolution, the participants had the eyes open watching the cross mark in the screen. The participants also underwent a neuropsychological CANTAB battery assessment where we could identify cognitive impairments in sensorimotor, attention, memory and executive functions domains in patients with DM1. The image postprocess analysis was done with specialized software FSL 5.0.8 using MELODIC package and PICA.

Publication: Lopez-Titla, M.M., Chirino, A., Cruz Solis, S.V., Hernandez-Castillo, C.R., Diaz, R., Márquez-Quiroz, L.d.C., Magaña, J.J., Beltrán-Parrazal, L. and Fernandez-Ruiz, J. (2021), Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I. Journal of Neuroimaging, 31: 192-198. https://doi.org/10.1111/jon.12786

Presenters

  • Maria Lopez

    Universidad Veracruzana

Authors

  • Maria Lopez

    Universidad Veracruzana

  • Juan Fernandez-Ruiz

    Universidad Nacional Autonoma de Mexico

  • Carlos Hernandez-Castillo

    Universidad Veracruzana

  • Jonathan Magaña-Aguirre

    Instituto Nacional de Rehabilitación

  • Luz Marquez-Quiroz

    Instituto Nacional de Rehabilitación

  • Amanda Chirino

    Facultad de Medicina, UNAM

  • Rosalinda Diaz

    Facultad de Medicina, UNAM

  • Luis Parrazal

    Universidad Veracruzana

  • Sara Cruz-Solis

    Facultad de Medicina, UNAM

  • Maria de Lourdes Martinez

    INPRFM